Moderna, Inc.'s (MRNA) CEO Stephane Bancel on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
Moderna Stock Surges After Covid Vaccine Sales Obliterate ExpectationsInvestors Business Daily • 08/03/22
Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shotsCNBC • 08/03/22
Moderna's stock rises 3% after beating earnings expectations in the second quarterMarket Watch • 08/03/22
Moderna Reports Second Quarter 2022 Financial Results and Provides Business UpdatesAccesswire • 08/03/22
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future'Market Watch • 07/29/22
LA County dodges face mask mandate as community transmission rates stabilize, and government orders 66 million doses of Moderna's pending boosterMarket Watch • 07/29/22
U.S. to pay Moderna $1.7 billion for 66 million doses of a new COVID-19 vaccine boosterMarket Watch • 07/29/22